SinoMab BioScience Limited

HKEX:3681.HK

1.13 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Revenue 6.081-4.0778.469-3.4257.45726.657012.7600000000000
Cost of Revenue 1.48300.9430000000000000000
Gross Profit 4.598-4.0777.526-3.4257.45726.657012.7600000000000
Gross Profit Ratio 0.75610.8891110100000000000
Reseach & Development Expenses 55.03568.65966.7598.23782.131109.13189.98255.58647.816181.56232.7853.58653.58611.82111.82111.8218.1518.1518.151
General & Administrative Expenses 34.20547.24150.248.57833.84999.07432.86121.05550.0349.2712.01915.38615.3860.5040.5040.5040.2480.2480.248
Selling & Marketing Expenses 00.17400.16401.46500.92500.255000000000
SG&A 34.20547.41550.248.74233.849100.53932.86121.9850.0349.52512.01915.38615.3860.5040.5040.5040.2480.2480.248
Other Expenses 0000000000-137.943-137.943-137.943-26.024-26.024-26.024-18.297-18.297-18.297
Operating Expenses 89.24116.074138.42143.703149.107213.857111.90470.97479.316231.89645.041-68.972-68.972-13.7-13.7-13.7-9.899-9.899-9.899
Operating Income -84.642-120.151-109.424-150.404-108.523-183.013-122.843-64.806-97.846-231.087-44.799-68.972-68.972-13.7-13.7-13.7-9.899-9.899-9.899
Operating Income Ratio -13.91929.47-12.92143.914-14.553-6.8650-5.07900000000000
Total Other Income Expenses Net -5.9811.136-24.67210.036-35.2679.2228.4423.04617.0061.151-1.547-0.099-0.099-7.203-7.203-7.203-3.077-3.077-3.077
Income Before Tax -90.622-109.015-134.096-140.368-143.79-173.791-114.403-41.76-80.84-229.936-46.346-69.071-69.071-20.903-20.903-20.903-12.975-12.975-12.975
Income Before Tax Ratio -14.90226.739-15.83440.983-19.283-6.520-3.27300000000000
Income Tax Expense 00000000000.4860.4860.486-6.445-6.445-6.445-2.336-2.336-2.336
Net Income -90.622-109.015-134.096-140.368-143.79-173.791-114.403-41.76-80.84-229.936-46.346-69.071-69.071-20.903-20.903-20.903-11.994-11.994-11.994
Net Income Ratio -14.90226.739-15.83440.983-19.283-6.520-3.27300000000000
EPS -0.085-0.11-0.13-0.14-0.15-0.18-0.11-0.042-0.08-0.26-0.058-0.083-0.083-0.021-0.021-0.021-0.012-0.012-0.012
EPS Diluted -0.085-0.11-0.13-0.14-0.15-0.18-0.11-0.042-0.08-0.26-0.058-0.083-0.083-0.021-0.021-0.021-0.012-0.012-0.012
EBITDA -75.075-108.334-102.107-140.484-103.81-175.607-120.822-62.376-96.234-229.76-43.89-66.364-66.364-18.81-18.81-18.81-10.024-10.024-10.024
EBITDA Ratio -12.34626.572-12.05741.017-13.921-6.5880-4.88800000000000